218 related articles for article (PubMed ID: 30320408)
1. A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens.
Altmann DM
Immunology; 2018 Nov; 155(3):283-284. PubMed ID: 30320408
[TBL] [Abstract][Full Text] [Related]
2. [From the time in the wilderness to the Nobel Prize in Physiology or Medicine awarded to James Allison and Tasuku Honjo: the Long March of cancer immunotherapy].
Fridman WH; Teillaud JL
Med Sci (Paris); 2019 Apr; 35(4):367-373. PubMed ID: 31038116
[No Abstract] [Full Text] [Related]
3. [Cancer immunotherapy crowned with Nobel Prize in Physiology or Medicine awarded to James Allison and Tasuku Honjo].
Teillaud JL
Med Sci (Paris); 2019 Apr; 35(4):365-366. PubMed ID: 31038115
[No Abstract] [Full Text] [Related]
4. Immune checkpoint inhibitors win the 2018 Nobel Prize.
Huang PW; Chang JW
Biomed J; 2019 Oct; 42(5):299-306. PubMed ID: 31783990
[TBL] [Abstract][Full Text] [Related]
5. Putting the Immunologic Brakes on Cancer.
Wolchok J
Cell; 2018 Nov; 175(6):1452-1454. PubMed ID: 30500529
[TBL] [Abstract][Full Text] [Related]
6. Nobel committee honors tumor immunologists.
Rotte A; D'Orazi G; Bhandaru M
J Exp Clin Cancer Res; 2018 Oct; 37(1):262. PubMed ID: 30376854
[TBL] [Abstract][Full Text] [Related]
7. Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing.
Li Z; Song W; Rubinstein M; Liu D
J Hematol Oncol; 2018 Dec; 11(1):142. PubMed ID: 30577797
[TBL] [Abstract][Full Text] [Related]
8. Translation of cancer immunotherapy from the bench to the bedside.
Guo Q; Huang F; Goncalves C; Del Rincón SV; Miller WH
Adv Cancer Res; 2019; 143():1-62. PubMed ID: 31202357
[TBL] [Abstract][Full Text] [Related]
9. New principles of cancer therapy give new hope for oncological patients.
Bernadic M; Duchon R; Aziri R; Mladosievicova B
Bratisl Lek Listy; 2019; 120(1):15-18. PubMed ID: 30685987
[TBL] [Abstract][Full Text] [Related]
10. Development of immune checkpoint therapy for cancer.
Fritz JM; Lenardo MJ
J Exp Med; 2019 Jun; 216(6):1244-1254. PubMed ID: 31068379
[TBL] [Abstract][Full Text] [Related]
11. [Allergies as a target of interest in the era of immunotherapy].
Gutiérrez-de Anda KV; Juárez-Martínez LA; Juárez-Avendaño G; Pelayo R; Balandrán JC
Rev Med Inst Mex Seguro Soc; 2019 Dec; 57(6):379-386. PubMed ID: 33001614
[TBL] [Abstract][Full Text] [Related]
12. [Immune checkpoint inhibitors. A breakthrough in cancer therapy].
Cárdenas-Oyarzo AM; Bocchieri-Oyarce PA; Méndez-Laport CR; Zolezzi JM; Ríos JA
Rev Med Chil; 2022 Jan; 150(1):93-99. PubMed ID: 35856970
[TBL] [Abstract][Full Text] [Related]
13. CAR T Cell Therapy Progress and Challenges for Solid Tumors.
Stern LA; Jonsson VD; Priceman SJ
Cancer Treat Res; 2020; 180():297-326. PubMed ID: 32215875
[TBL] [Abstract][Full Text] [Related]
14. The 2018 Nobel Prize in Physiology or Medicine: An exemplar of bench to bedside in immunology.
Ballas ZK
J Allergy Clin Immunol; 2018 Dec; 142(6):1752-1753. PubMed ID: 30539724
[No Abstract] [Full Text] [Related]
15. The Intriguing History of Cancer Immunotherapy.
Dobosz P; Dzieciątkowski T
Front Immunol; 2019; 10():2965. PubMed ID: 31921205
[TBL] [Abstract][Full Text] [Related]
16. Cancer immunologists scoop medicine Nobel prize.
Ledford H; Else H; Warren M
Nature; 2018 Oct; 562(7725):20-21. PubMed ID: 30279600
[No Abstract] [Full Text] [Related]
17. Role of miRNAs in immune responses and immunotherapy in cancer.
Cortez MA; Anfossi S; Ramapriyan R; Menon H; Atalar SC; Aliru M; Welsh J; Calin GA
Genes Chromosomes Cancer; 2019 Apr; 58(4):244-253. PubMed ID: 30578699
[TBL] [Abstract][Full Text] [Related]
18. Structures of Immune Checkpoints: An Overview on the CD28-B7 Family.
Liu W; Zang X
Adv Exp Med Biol; 2019; 1172():63-78. PubMed ID: 31628651
[TBL] [Abstract][Full Text] [Related]
19. MAGE-A antigens as targets in tumour therapy.
Meek DW; Marcar L
Cancer Lett; 2012 Nov; 324(2):126-32. PubMed ID: 22634429
[TBL] [Abstract][Full Text] [Related]
20. Cancer Immunotherapy: An Overview of Small Molecules as Inhibitors of the Immune Checkpoint PD-1/PD-L1 (2015-2021).
Baglini E; Salerno S; Barresi E; Marzo T; Settimo FD; Taliani S
Mini Rev Med Chem; 2022; 22(14):1816-1827. PubMed ID: 35176979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
